{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:30:57Z","timestamp":1707525057132},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,6]]},"DOI":"10.7759\/cureus.38648","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T22:33:25Z","timestamp":1683412405000},"source":"Crossref","is-referenced-by-count":0,"title":["Unveiling of Type B Lactic Acidosis From Systemic Lupus Erythematosus-Associated B-cell Lymphoma: A Fatal Oncology Emergency"],"prefix":"10.7759","author":[{"given":"Yashitha","family":"Chirumamilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nageshwari","family":"Palanisamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekwevugbe Ochuko O","family":"Ogbon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Chinnappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Krznarich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghassan","family":"Bachuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Berrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(76)80789-2","article-title":"The clinical presentation and classification of lactic acidosis","author":"Cohen RD","year":"1976","unstructured":"Cohen RD, Woods HF. The clinical presentation and classification of lactic acidosis. M.C. Scrutton (ed): Blackwell Scientific Publications, Oxford, London; 1976. 10.1016\/0014-5793(76)80789-2"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ph15121496","article-title":"Lactic acidosis related to pharmacotherapy and human diseases","volume":"15","author":"Zanza C","year":"2022","unstructured":"Zanza C, Facelli V, Romenskaya T, et al.. Lactic acidosis related to pharmacotherapy and human diseases\r\n. Pharmaceuticals (Basel). 2022, 15:1496. 10.3390\/ph15121496","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14737","article-title":"Burkitt lymphoma and lactic acidosis: a case report and review of the literature","volume":"9","author":"Looyens C","year":"2021","unstructured":"Looyens C, Giraud R, Neto Silva I, Bendjelid K. Burkitt lymphoma and lactic acidosis: a case report and review of the literature. Physiol Rep. 2021, 9:e14737. 10.14814\/phy2.14737","journal-title":"Physiol Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2013.0099","article-title":"The chemistry, physiology and pathology of pH in cancer","volume":"369","author":"Swietach P","year":"2014","unstructured":"Swietach P, Vaughan-Jones RD, Harris AL, Hulikova A. The chemistry, physiology and pathology of pH in cancer. Philos Trans R Soc Lond B Biol Sci. 2014, 369:20130099. 10.1098\/rstb.2013.0099","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2010.12.013","article-title":"Lactate: biomarker and potential therapeutic target","volume":"27","author":"Okorie ON","year":"2011","unstructured":"Okorie ON, Dellinger P. Lactate: biomarker and potential therapeutic target. Crit Care Clin. 2011, 27:299-326. 10.1016\/j.ccc.2010.12.013","journal-title":"Crit Care Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2478\/jccm-2019-0010","article-title":"Refractory lactic acidosis and an approach to its management - a case report","volume":"5","author":"He Y","year":"2019","unstructured":"He Y, Ong J, Ong S. Refractory lactic acidosis and an approach to its management - a case report. J Crit Care Med (Targu Mures). 2019, 5:60-5. 10.2478\/jccm-2019-0010","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2011.125","article-title":"Type B lactic acidosis secondary to malignancy: case report, review of published cases, insights into pathogenesis, and prospects for therapy","volume":"11","author":"Ruiz JP","year":"2011","unstructured":"Ruiz JP, Singh AK, Hart P. Type B lactic acidosis secondary to malignancy: case report, review of published cases, insights into pathogenesis, and prospects for therapy. ScientificWorldJournal. 2011, 11:1316-24. 10.1100\/tsw.2011.125","journal-title":"ScientificWorldJournal"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26557","article-title":"An oncological emergency: Severe type B lactic acidosis from Warburg effect in diffuse large B-cell lymphoma","volume":"14","author":"Sanivarapu R","year":"2022","unstructured":"Sanivarapu R, Upadrista PK, Otero-Colon J, Shah K, Cadet B, Tao Q, Iqbal J. An oncological emergency: Severe type B lactic acidosis from Warburg effect in diffuse large B-cell lymphoma. Cureus. 2022, 14:e26557. 10.7759\/cureus.26557","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.06.012","article-title":"Etiology and therapeutic approach to elevated lactate levels","volume":"88","author":"Andersen LW","year":"2013","unstructured":"Andersen LW, Mackenhauer J, Roberts JC, Berg KM, Cocchi MN, Donnino MW. Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc. 2013, 88:1127-40. 10.1016\/j.mayocp.2013.06.012","journal-title":"Mayo Clin Proc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2005.04.004","article-title":"Metabolic emergencies","volume":"58","author":"Spinazz\u00e9 S","year":"2006","unstructured":"Spinazz\u00e9 S, Schrijvers D. Metabolic emergencies. Crit Rev Oncol Hematol. 2006, 58:79-89. 10.1016\/j.critrevonc.2005.04.004","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2017.09.013","article-title":"A review on SLE and malignancy","volume":"31","author":"Choi MY","year":"2017","unstructured":"Choi MY, Flood K, Bernatsky S, Ramsey-Goldman R, Clarke AE. A review on SLE and malignancy. Best Pract Res Clin Rheumatol. 2017, 31:373-96. 10.1016\/j.berh.2017.09.013","journal-title":"Best Pract Res Clin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/154955-unveiling-of-type-b-lactic-acidosis-from-systemic-lupus-erythematosus-associated-b-cell-lymphoma-a-fatal-oncology-emergency","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:02Z","timestamp":1707508682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/154955-unveiling-of-type-b-lactic-acidosis-from-systemic-lupus-erythematosus-associated-b-cell-lymphoma-a-fatal-oncology-emergency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,6]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.38648","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,6]]}}}